Abbott Laboratories Stock News

The Oncology Molecular Diagnostics identify the presence of cancer cells by analyzing their biological molecules. Several tests are performed on the blood, saliva, and tumor tissue samples for detecting and measuring specific genetic sequences in the DNA, RNA, and cell

We've just hit the best time of the year to roll out one of our most potent dividend “hacks.”

Beacon Financial Group boosted its holdings in Abbott Laboratories (NYSE:ABT) by 8.4% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 13,143 shares of the healthcare product maker’s stock after buying an additional 1,021 shares during the quarter. Beacon Financial Group’s holdings in Abbott […]

Kiplinger Investing publishes opportune source-lists for investors online. Two recent billionaires stock-lists by Dan Burrows were published 6/1/21 and 9/9/21. 20 of the 37 billionaire-held stocks pay

The ASEAN and North Asian Point of Care/Rapid Diagnostics Market study analyzes the market status, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors, and Porter''s Five Forces Analysis. This research report encompasses

CNBC's Meg Tirrell joins 'Squawk Box' to report on the increased demand for Covid-19 tests ahead of the Thanksgiving holiday.

BFT Financial Group LLC reduced its position in shares of Abbott Laboratories (NYSE:ABT) by 2.8% in the 3rd quarter, HoldingsChannel reports. The firm owned 5,186 shares of the healthcare product makers stock after selling 148 shares during the period. BFT Financial Group LLCs holdings in Abbott Laboratories were worth $613,000 as of its most recent []

Altfest L J & Co. Inc. trimmed its stake in Abbott Laboratories (NYSE:ABT) by 7.7% during the 3rd quarter, HoldingsChannel reports. The fund owned 14,009 shares of the healthcare product makers stock after selling 1,173 shares during the quarter. Altfest L J & Co. Inc.s holdings in Abbott Laboratories were worth $1,655,000 as of its []

BIMI International Medical Inc. (BIMI) with the stream of -9.26% also noticed, India Abbott Laboratories (ABT) encountered a rapid change of -0.63% in the last hour of Fridays trading session. The post Sizzling Stock Alert: BIMI International Medical Inc. (NASDAQ:BIMI), Abbott Laboratories (NYSE:ABT) appeared first on Stocks Equity .

Grassi Investment Management boosted its position in shares of Abbott Laboratories (NYSE:ABT) by 0.5% during the third quarter, Holdings Channel.com reports. The fund owned 113,090 shares of the healthcare product makers stock after acquiring an additional 525 shares during the quarter. Abbott Laboratories accounts for 1.5% of Grassi Investment Managements investment portfolio, making the stock []

Lynch & Associates IN decreased its position in Abbott Laboratories (NYSE:ABT) by 0.7% during the 3rd quarter, Holdings Channel.com reports. The fund owned 67,030 shares of the healthcare product makers stock after selling 501 shares during the quarter. Abbott Laboratories comprises 2.1% of Lynch & Associates INs investment portfolio, making the stock its 15th largest []

Wesbanco Bank Inc. boosted its stake in shares of Abbott Laboratories (NYSE:ABT) by 0.2% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 145,319 shares of the healthcare product makers stock after acquiring an additional 220 shares during the quarter. Wesbanco Bank []

Level Four Advisory Services LLC lowered its position in shares of Abbott Laboratories (NYSE:ABT) by 42.0% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 15,036 shares of the healthcare product makers stock after selling 10,907 shares during the period. Level Four Advisory Services LLCs []

Piscataqua Savings Bank lowered its stake in shares of Abbott Laboratories (NYSE:ABT) by 1.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,064 shares of the healthcare product makers stock after selling 107 shares during the quarter. Abbott []